Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder.
Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage.
Endogenous hypothermic response to hypoxia reduces brain injury: Implications for modeling hypoxic-ischemic encephalopathy and therapeutic hypothermia in neonatal mice.
Vascularized nerve grafts: an experimental study.
Nuclear Protein Kinase CLK1 Uses A Nontraditional Docking Mechanism To Select Physiological Substrates.
Commentary on: Predictive value of health-related quality of life in progression of disability and depression in persons with multiple sclerosis: a 3-year study.
Juvenile striatal white matter is resistant to ischemia-induced damage.
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Coping with Multiple Sclerosis Scale: Reconsideration of the Factorial Structure.
Subcutaneous vs. Intravenous Immunoglobulin for Chronic Autoimmune Neuropathies: A Meta-analysis.
Heterogeneous depression trajectories in multiple sclerosis patients.
Knockdown of Unconventional Myosin ID Expression Induced Morphological Change in Oligodendrocytes.
Poster 304 Protracted Course of Inpatient Rehabilitation in a Patient with Severe Acute Demyelinating Polyneuropathy.
NG2-glia, More Than Progenitor Cells.
Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease.
Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis.
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA.
Anthraquinones As Pharmacological Tools and Drugs.
Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection.
Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis.
Morphofunctional Changes in the Tibial and Peroneal Nerves in Shin Lengthening Using High Speed Daily Distraction Technique.
[Multiple Sclerosis and Commensal Gut Flora].
Structural Alterations of Segmented Macular Inner Layers in Aquaporin4-Antibody-Positive Optic Neuritis Patients in a Chinese Population.
Current status of biomarker research in neurology.
Compromised blood-brain barrier permeability: Novel mechanism by which circulating angiotensin II signals sympathoexcitatory centers during hypertension.
Pages
« first
‹ previous
…
778
779
780
781
782
783
784
785
786
…
next ›
last »